Trials
Search / Trial NCT05655741

Modified Delphi for Genomic Bereavement Care

Launched by THE LEEDS TEACHING HOSPITALS NHS TRUST · Dec 16, 2022

Trial Information

Current as of January 16, 2025

Completed

Keywords

ClinConnect Summary

There is a lack of guidance available as to how to care for women and families who suffer a pregnancy loss where fetal anomalies have been found and a genetic cause is suspected. As it is estimated that 1 in 4 pregnancies end in loss, these families make up a significant proportion of the population that maternity services care for and with no consensus in this area many families may have a poor experience.

As the field of genomics rapidly advances, it is important that patient care reflects the changes in practice and that the most appropriate tests and support are offered. All aspects of...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants must belong to one of the relevant stakeholder groups; Maternal and fetal medicine consultants or obstetricians with a special interest in fetal medicine, Clinical geneticists with an interest in prenatal genomics, Perinatal pathologists Clinical scientists with an interest in genomics, Bereavement midwives.
  • Exclusion Criteria:
  • Nil if inclusion criteria are met

Trial Officials

Abigail Hyland, MBBS

Principal Investigator

Leeds Teaching Hospitals Trust

About The Leeds Teaching Hospitals Nhs Trust

The Leeds Teaching Hospitals NHS Trust is a prominent healthcare organization in the United Kingdom, renowned for its commitment to delivering high-quality patient care, innovative research, and advanced medical education. As a leading clinical trial sponsor, the Trust plays a pivotal role in facilitating cutting-edge research initiatives that aim to improve health outcomes and advance medical knowledge. With a multidisciplinary team of experts and access to state-of-the-art facilities, the Trust is dedicated to fostering collaboration and ensuring the highest ethical standards in clinical research, ultimately contributing to the development of new treatments and therapies for diverse patient populations.

Locations

Leeds, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials